Home › Funds › Enavate Sciences GP, LLC › CAMP

Enavate Sciences GP, LLC position in CAMP

CAMP4 THERAPEUTICS CORP · Health Care

Enavate Sciences GP, LLC reported holding 1,425,541 shares of CAMP (CAMP4 THERAPEUTICS CORP) in its Q2 2026 13F filing — a position valued at US$6.2M, representing 1.80% of its reported portfolio and ranking #7 among its reported holdings. Enavate Sciences GP, LLC has disclosed CAMP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)1.43M sh
Reported value held$6.23M
Portfolio Weight1.80%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Enavate Sciences GP, LLC's CAMP position evolved

Enavate Sciences GP, LLC first disclosed a stake in CAMP in Q4 2024 at 3,785,802 shares (US$19.8M). Across 7 filings, Enavate Sciences GP, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,425,541 shares valued at US$6.2M — a reduction of -765,379 shares quarter over quarter.. Notable position changes include a 28% trim in Q1 2026 (shares were roughly flat over the following quarter), a 35% trim in Q2 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 3.79M $19.76M New
Q1 2025 3.79M $15.14M Hold
Q2 2025 3.79M $5.49M Hold
Q3 2025 3.79M $11.36M Hold
Q4 2025 3.04M $18.61M Reduce
Q1 2026 2.19M $9.66M Reduce
Q2 2026 1.43M $6.23M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAMP and 13F data

CAMP (CAMP4 THERAPEUTICS CORP) is a Health Care company. 37 other funds we track also report a position in CAMP — the largest reported positions include 5AM Venture Management, LLC (US$25.6M), Vivo Capital, LLC (US$18.6M), a16z Capital Management, L.L.C. (US$9.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAMP

All CAMP fund holders →

FAQ

How long has Enavate Sciences GP, LLC held CAMP?

Enavate Sciences GP, LLC has disclosed CAMP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Enavate Sciences GP, LLC's current position in CAMP?

As of Q2 2026, Enavate Sciences GP, LLC holds 1.43M shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $6.23M, representing 1.80% of its reported portfolio and ranking #7.

Has Enavate Sciences GP, LLC been buying or selling CAMP?

In the latest 13F filing (Q2 2026), Enavate Sciences GP, LLC reduced its position in CAMP.

Which other funds hold CAMP?

Other major institutional holders of CAMP include 5AM Venture Management, LLC, Vivo Capital, LLC, a16z Capital Management, L.L.C., among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.